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DObjective:We sought to determine if the radial artery (RA) or the free right internal thoracic artery (RITA) is the
better conduit to bypass the circumflex coronary artery during coronary artery bypass grafting (CABG) using the
left internal thoracic artery (LITA).
Methods: Propensity matching was performed on 2488 CABG-LITA patients from 2 affiliated centers, resulting
in 528 pairs who received either a RA at one center or a free RITA at the other center to bypass the circumflex
coronary artery from 1995 to 2009.
Results:Kaplan Meier estimated 1-, 5-, 10-, and 15-year survival rates were 99%, 95%, 85%, and 76% for RA
patients, respectively, and 97%, 92%, 80%, and 71% for RITA patients, respectively (P¼ .060). Major adverse
events (MAEs) were fewer in the RA group (7.6% vs 14.0%; P ¼ .001) and use of the RA was a significant
predictor of reduced MAEs (odds ratio [OR], 0.48; P ¼ .002) in all patients and especially in diabetic (OR,
0.32; P ¼ .003), older (OR, 0.40; P ¼ .009), obese (OR, 0.15; P<.001), and chronic obstructive pulmonary
disease (COPD) (OR, 0.05; P ¼ .016) patients. However, survival was better with RA only in COPD (hazard
ratio, 0.49; P¼ .045) and older (hazard ratio, 0.71; P¼ .050) patients. Overall RA patency (83.9%) was similar
to RITA patency (87.4%) at a mean of 5.1  3.8 years (P ¼ .155).
Conclusions: Long-term survival is similar in CABG-LITA patients using either a RA or free RITA graft to
bypass the circumflex coronary artery. RA grafting has fewer MAEs, a similar patency to RITA, and improves
survival in older and COPD patients. The choice of the second arterial conduit should be guided by patient
profiles and surgeon preferences. (J Thorac Cardiovasc Surg 2014;147:133-42)The addition of a second arterial conduit improves long-term
survival after coronary artery bypass grafting (CABG) using
the left internal thoracic artery (LITA). Numerous studies1-4
have shown a clear survival advantage of adding a right
internal thoracic artery (RITA) compared with using the
saphenous vein (SV). Similarly, multiple studies5-8 have
shown that the radial artery (RA) also has a strong survival
benefit compared with SV grafting. Given the limitations
of SV grafting, multiple arterial grafting is thus the
increasingly recognized and recommended optimal
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The Journal of Thoracic and CaHowever, it is unclear if the RA or the RITA is the better
second arterial conduit10-12 during CABG-LITA. Several
investigators13,14 have reported the RA to be the better
option, some investigators15 have found no difference,
whereas others16 have reported the RITA to be superior.
All of these comparative studies had small numbers of
patients, short- to midterm follow-up periods, and a high
proportion of bypassing the right coronary artery with the
second arterial graft. We sought to better define the second
best arterial graft by comparing outcomes in propensity-
matched patients receiving either a RA or free RITA to
the circumflex coronary artery during CABG with LITA
to the left anterior descending artery.METHODS
Patients
We performed a retrospective cohort study of our 2 affiliated institu-
tions’ experiences using either the RA or the RITA to bypass the circumflex
coronary artery during primary isolated CABG using the LITA to bypass
the left anterior descending artery from January 1995 to January 2009.
Beth IsraelMedical Center (BIMC) and St. Luke’s Roosevelt Hospital Cen-
ter (SLR) are closely affiliated as part of ContinuumHealth Partners in New
York, NY. Both centers maintain an identical New York State–mandated,
prospectively collected database. BIMC used the RA as the primary second
arterial conduit and SLR used the free RITA. Patients received additionalrdiovascular Surgery c Volume 147, Number 1 133
Abbreviations and Acronyms
BIMC ¼ Beth Israel Medical Center
BITA ¼ bilateral internal thoracic artery
CABG ¼ coronary artery bypass grafting
COPD ¼ chronic obstructive pulmonary disease
HR ¼ hazard ratio
LITA ¼ left internal thoracic artery
MAE ¼ major adverse event
OR ¼ odds ratio
PS ¼ propensity score
RCA ¼ right coronary artery
RCT ¼ randomized controlled trial
RITA ¼ right internal thoracic artery
SITA ¼ left internal thoracic artery and saphenous
vein grafts
SLR ¼ St. Luke’s Roosevelt Hospital Center
SV ¼ saphenous vein
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D SV grafts as needed. All data were sent to the New York State Department
of Health and also are maintained in a separate institutional database using
Microsoft Access (Redmond, Wash). This study was approved by the
medical centers’ respective Institutional Review Boards, which waived
written informed consent.
RA use at BIMC was at first selective, with approximately 33% of
CABG patients receiving a RA for indications of age younger than 65 years
or unavailable venous conduit. Contraindications to RA use were hemodi-
alysis or chronic renal insufficiency, Raynaud’s disease, and, more recently,
radial artery catheterization. Overtime, use gradually increased. Currently,
75% of all patients receive a RA at BIMC using a liberalized age limit of
younger than 80 years. Average total RA use was 43% over the past 17
years whereas RITA use at SLR has been consistently very high at near
60%. There are no age restrictions at SLR and there were no contraindica-
tions to using a RITA graft. These different institutional grafting strategies
resulted in a much younger RA population at BIMC than the SLR RITA
group, as seen in Table 1.
A total of 6566 patients had isolated primary CABG using the LITA at
BIMC (n ¼ 4385) and at SLR (n ¼ 2181) during the study period.
Forty-one percent of these patients (2707) received a second arterial graft
while the other 3859 patients received a LITA and SV grafts (SITA). RA
and RITA were used mainly to bypass the circumflex vessels although
the right coronary artery (RCA) occasionally was bypassed with these
conduits. A total of 108 patients (98 at BIMC and 10 at SLR) receiving
the second arterial graft to the RCA were excluded. The primary conduit
to bypass the RCA was thus the SV. In addition, 111 patients (35 at
BIMC and 76 at SLR) receiving both RA and RITA grafts were excluded.
This resulted in 2488 patients at both institutions available for study: 1334
RA patients at BIMC and 1154 RITA patients at SLR.
Surgical Techniques
CABG was performed mostly on pump using cold blood cardioplegic
arrest. Crystalloid cardioplegia was used early in the SLR experience.
Off-pump surgery (1.1% of procedures at both BIMC and SLR) was
performed when aortic disease precluded the safe use of cross-clamping
or cardiopulmonary bypass. The RITA nearly always was used as a free
graft. Both RA and RITA grafts were used as aortocoronary bypasses
except if a lack of length or aortic disease precluded direct aortic
anastomosis when the proximal anastomoses were performed on another
RA, SV, or, rarely, LITA. BIMC performed the proximal anastomoses using
a single cross-clamp techniquewhereas SLR used a partial occlusion clamp134 The Journal of Thoracic and Cardiovascular Surgto perform the proximal anastomoses after removal of the cross-clamp.
The RITA frequently was used as a sequential or Y graft 58% of the
time for the RITA compared with only 18% of RA patients. In RA and
RITA patients receiving more than 2 arterial grafts, an additional obtuse
marginal, a large diagonal, or a ramus branch usually were grafted as the
third arterial target vessel. SLR surgeons used the surgical microscope
with 123 magnification for all anastomoses.
Our technique of radial artery harvest and preparation has been
described previously.17 Since 2000, we have harvested all conduits using
an endoscopic approach. We previously found no advantage in open versus
endoscopic harvesting.18 The internal thoracic arteries were harvested as
pedicled grafts at both institutions. Occasional mechanical or papaverine
dilation of the ITAwas performed at both institutions.
Study End Points
The primary end points of the study were all-cause mortality and
perioperativemajor adverse events (MAEs), which included surgical death,
stroke, myocardial infarction, sternal wound infection, sepsis, reoperation
for bleeding, respiratory failure, and renal failure. The Social Security
Death Index (www.Genealogybank.com) was searched in October 2012
and was used to identify patients who died after hospital discharge. Surgi-
cal mortality included all patients who died during the index hospitalization
or within 30 days after surgery if discharged.
MAEswere collected prospectively andwere defined by theDepartment
of Health Cardiac Surgery Reporting System (http://www.health.ny.gov/
statistics/diseases/cardiovascular/index.htmNYS). All MAEs occurred
during the index hospitalization, except for sternal wound infection, which
was reported up to 6 months postoperatively.
A secondary end point was graft patency. Symptom-driven cardiac
catheterization was performed at our institutions on 17.7% of RA and
9.3% of RITA patients. We classified grafts as perfectly patent, diseased
with more than 70% disease, or occluded. Grafts with string signs (diffuse
narrowing of the graft to<1 mm or Thrombolysis in Myocardial Infarction
[TIMI] flow of 1) were considered occluded.
Propensity Matching and Statistical Analysis
All analyses were conducted using Stata statistical software version
12.1 (release 12; Stata Corporation, College Station, Tex). Univariate
comparisons between RA and RITA graft patients were conducted using
t tests for normally distributed variates and 2-sample proportion tests for
binary valued variates. Relationships with multivalued categoric variates
were evaluated using c2 tests.
Because of selection bias in assignment of patients to specific graft
types, a bias-reduction technique was used to allow testing of the relative
effect of RA grafts on survival and other postoperative outcomes. A logistic
propensity scoring model (based on the following significant predictors of
treatment probability: age, sex, ethnicity, year of surgery, ejection fraction,
priority, myocardial infarction, hypertension, chronic obstructive pulmo-
nary disease [COPD], heart failure, number of grafts, number of arterial
grafts, hemodialysis, and triple-vessel disease) was developed to
summarize covariate information regarding treatment selection (RA vs
RITA) into a single scalar value (propensity score [PS]) and subsequently
was used in a nearest-neighbor, caliper-constrained matching technique.19
A total of 1334 patients who had received a single RA graft were matched
against a sample of 1154 patients who had received a single RITA graft. A
total of 528 matched pairs (N ¼ 1056) of RA and RITA graft recipients
were identified and used for subsequent analysis.
Unadjusted long-term survival of the 2 covariate-matched patient/graft
subgroups was evaluated using Kaplan-Meier estimates and the log-rank
statistic. A Cox proportional hazard regression was conducted to evaluate
the hazard ratio of RA versus RITA adjusted for a set of covariates and
comorbidities that were selected in a stepwise fashion using backward
elimination. The proportional hazard assumption was tested and found to
have been met. The following independent variables were entered intoery c January 2014
TABLE 1. Comparison of radial artery and right internal mammary artery patients
Before propensity matching After propensity matching
Radial (n ¼ 1334) RITA (n ¼ 1154) P value Radial (n ¼ 528) RITA (n ¼ 528) P value
Years since CABG  SD 9.8  4.1 8.8  4.5 <.001 10.0  4.2 9.7  4.4 .292
All-cause mortality 13.7% 30.2% <.0001 17% 22.5% .025
Mean age (y  SD) 57.6  8.3 65.7  10.8 <.0001 60.0  7.9 61.0  11.0 .100
Male 83% 70.6% <.0001 78.4% 76.9% .555
Female 17% 29.4% <.0001 21.6% 23.1% .555
BMI  SD 29  5.9 28.2  5.4 .237 28.8  6.9 28.7  5.3 .615
Hispanic 20.9% 22.9% <.0001 0.205 0.223 .453
White 67.7% 66.8% .641 0.688 0.706 .503
Mean EF  SD 47.5  13.3 45.8  14.7 .002 47.3  13.6 47.5  14.4 .868
Transmural MI 36.3% 24.7% <.0001 30.9% 28.6% .419
Stroke 4.9% 4.7% .883 3.9% 5.5% .188
Cerebrovascular disease 5.4% 9.4% <.0001 6.8% 6.4% .805
Aortoiliac PVD 1.9% 3.2% .039 1.7% 2.7% .292
Femoral popliteal PVD 5.2% 9.6% <.0001 7.8% 8% .909
Hemodialysis 0.3% 3.0% <.0001 0.8% 0.8% 1.000
Creatinine value>2.5 mg 1.8% 3.0% <.001 1.9% 1.5% .634
Calcified aorta 3.8% 7.7% <.0001 5.1% 6.4% .356
Current CHF 6.8% 24.8% <.0001 10.8% 10% .687
COPD 18.5% 7.7% <.0001 10.4% 10% .839
Diabetes 37.6% 35.3% .237 36.6% 35.6% .749
Hypertension 66.6% 48.4% <.0001 56.8% 56.3% .852
Previous PCI 18.4% 13.4% .001 16.9% 15.5% .559
Coronary vessel disease
Triple 84.3% 91.7% <.0001 86.4% 86.9% .786
Double 11.5% 7.2% <.0001 10.4% 10.8% .842
Single 3.3% 0.9% <.0001 3% 1.7% .157
Left main 28% 30.3% .209 31.1% 29% .460
Mean cross-clamp time  SD 70.4  19.4 70.0  26.6 .658 69.3  21.9 67.0  25.8 .144
Mean Perfusion Time  SD 93.3  23.4 128.5  34.7 <.0001 92.6  25.2 125.0  34.4 <.0001
Grafts per patient:  SD 3.9  0.9 4.0  0.9 <.0001 3.8  0.9 3.8  0.9 .332
Arterial Grafts per patient  SD 2.4  0.6 3.1  0.7 <.0001 2.7  0.6 2.8  0.7 .016
Major adverse events:
Operative mortality 0.4% 1.8% <.0001 0.6% 1.7% .082
Permanent stroke 0.9% 2.4% .003 0.8% 2.1% .069
Myocardial Infarction 1.1% 0.3% .011 1.1% 0.6% .315
Sternal wound infection 1.1% 2.9% .001 1.1% 2.7% .071
Septicemia 0.8% 0.7% .707 0.8% 0.6% .705
Reoperation for bleeding 1.4% 2.5% .049 1.5% 1.9% .634
Respiratory failure 1.9% 4.5% <.0001 1.1% 4.0% .003
Renal failure 0.4% 1.6% .005 0.6% 0.6% 1.000
BMI, Body mass index; CHF, congestive heart failure; EF, ejection fraction; MI, myocardial infarction; PCI, percutaneous intervention; PVD, peripheral vascular disease;
RITA, right internal thoracic artery; CABG, coronary artery bypass grafting; COPD, chronic obstructive pulmonary disease; SD, standard deviation.
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betes, hypertension, ejection fraction, COPD, age, femoral popliteal
peripheral vascular disease, and congestive heart failure.
To further confirm that the choice of conduit had an independent effect
on postoperative MAEs, we developed a logistic model for MAEs to
estimate the effect of the conduit, adjusted for the PS, on all unmatched
patients. We also developed a Cox proportional hazards regression model
to estimate the hazard of death in RA patients referenced to RITA patients.
The model was adjusted using the PS to reduce selection bias. We also per-
formed a propensity analysis in the 3859 concurrent patients undergoing
CABG using LITA and only SV grafts at both institutions. Of the 2918
BIMC patients and the 941 SLR patients, 571matched pairs were analyzed.
Finally, we compared our institutions’ risk-adjusted mortality using theThe Journal of Thoracic and CaNew York State Department of Health Cardiac Surgery Reporting System
data available on their website (http://www.health.ny.gov/statistics/
diseases/cardiovascular/index).RESULTS
Patient Data and Survival
Table 1 shows the patient risk factors, intraoperative data,
and MAEs for unmatched and matched RA and RITA
patients. Briefly, the unmatched RA patients were
much younger (average age, 57.6 y for RA compared
with 65.7 y for RITA patients) and mostly malerdiovascular Surgery c Volume 147, Number 1 135
FIGURE 1. A, Comparison of the unadjusted Kaplan-Meier estimated
survival for all RA and RITA patients (P < .0001, log-rank test).
B, Comparison of the Kaplan-Meier survival for propensity-matched RA
and RITA patients (P¼ .060, log-rank test).CABG, Coronary artery bypass
grafting; RA, radial artery; RITA, right internal thoracic artery.
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number of diabetic patients. Coronary artery disease was
more extensive in the RITA group, but the number of bypass
grafts per patient was similar (RA, 3.9; RITA, 4.0) in both
groups. The RA unmatched patients had 2.4  0.6 arterial
grafts per patient compared with 3.1  0.7 arterial grafts
per patient for the RITA patients, reflecting the prevalent
use of sequential grafting using the RITA (and often the
LITA) in the RITA group. In all, 31% of the RA patients
and 79% of the RITA patients received more than 2 arterial
grafts. Among RA patients, 18% had sequential or Y grafts,
6.6% had bilateral RA grafts, and a long RA occasionally
could be used for 2 individual aortocoronary grafts. For
RITA patients, 58% had sequential or Y grafts. Sequential
LITA grafting was performed in 43% of the RITA patients
and in 3.8% of the RA patients.
Long-term follow-up evaluation averaged 9.0 4.3 years
for the RA patients and 8.5  4.6 years for the RITA
patients, with a range 0.1 to 16 years. There were a total
of 178 postdischarge deaths in the RA group and 327
postdischarge deaths in the RITA group. Including the
surgical deaths, the total all-cause mortality was 13.7% in
the RA patients and 30.2% in the RITA patients
(P < .0001). Long-term Kaplan-Meier survival strongly
favored RA grafting in the unmatched patients as seen in
Figure 1, A (log-rank test, P < .0001). As outlined in
Table 1, better outcomes and fewer major complications
in the RA group likely reflected the significantly older
age, more extensive disease, and more co-morbidities in
the unmatched RITA patients.
RA use was a strong predictor of decreased MAEs
(OR, 0.49; 95% confidence interval [CI], 0.32-0.77;
P ¼ .002) in all unmatched patients after adjustment using
the propensity-adjusted logistic model. In addition, after
adjustment using the PS-adjusted Cox regression model,
RA use was found not to be a predictor of mortality (hazard
ratio [HR], 0.87; 95% CI, 0.67-1.14; P ¼ .322).
Propensity-Matched Patient Outcomes
Table 1 shows the matched RA and RITA data in 1056
patients. The 2 groups were well matched by age, sex,
vascular disease, diabetes, left ventricular function, extent
of disease, and completeness of revascularization. Cross-
clamp times were the same before and after matching.
Perfusion times were longer in the RITA group, reflecting
the additional time for use of the surgical microscope and
more sequential grafting.
Table 1 also shows the MAEs for the matched patients.
There was a trend toward more strokes and sternal
wound infections in the RITA patients and significantly
more respiratory failure (P ¼ .003). All MAEs were fewer
in the RA group (7.6% vs 14.0%; P ¼ .001). After
adjusting for multiple comparisons, rates of respiratory
failure (Sidak-adjusted P ¼ .031) and overall MAEs136 The Journal of Thoracic and Cardiovascular Surg(Sidak-adjusted P ¼ .023) remained significantly better
using the RA. Finally, logistic regression modeling showed
that use of a RA conduit was a significant predictor
of reduced MAEs (odds ratio [OR], 0.48; 95% CI,
0.30-0.77; P ¼ .002).
Hospital and 30-day mortality was 0.6% for the RA and
1.7% for the RITA patients, which was not statistically
different (P¼ .082). There were an additional 87 late deaths
(16.6%) in the RA group and 110 late deaths (21.2%) in the
RITA group. After excluding early hospital deaths,
propensity-matched RA and RITA patients had similar
long-term Kaplan-Meier survival as seen in Figure 1, B.
Ten-year survival was 85% for RA and 80% for RITA
patients, which was not statistically significant (log-rank
test, P ¼ .060). The corresponding 0- to 15-year mortality
rate was 20.8% higher for the RITA group. Combined early
and late all-cause mortality was 17% for RA and 22.5% for
RITA patients (P ¼ .025).ery c January 2014
TABLE 3. Adjusted HRs for death and adjusted ORs for MAEs in
propensity-matched patient subgroups
Risk factor
Patients,
n HR (95% CI)
P
value OR (95% CI)
P
value
Diabetes 381
RA 193 0.86 (0.57-1.29) .474 0.32 (0.15-0.68) .003
RITA 188 Reference Reference
Obesity 373
RA 181 0.88 (0.56-1.38) .578 0.15 (0.06-0.39) <.001
RITA 192 Reference Reference
COPD 108
RA 55 0.49 (0.24-0.98) .045 0.05 (0.01-0.57) .016
RITA 53 Reference Reference
Female 236
RA 114 0.97 (0.55-1.70) .914 0.40 (0.16-1.00) .051
RITA 122 Reference Reference
EF<40% 335
RA 150 0.74 (0.48-1.12) .153 0.47 (0.20-1.11) .087
RITA 185 Reference Reference
Age>60 y 519
RA 241 0.71 (0.51-0.99) .050 0.40 (0.20-0.79) .009
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Although use of a RA graft decreased mortality by 15%,
RA use was not an independent predictor of decreased
mortality (HR, 0.85; 95% CI, 0.64-1.13; P ¼ .257).
COPD, diabetes, peripheral vascular disease, congestive
heart failure, hypertension, a calcified ascending aorta,
age, and left ventricular function were all independent
predictors of increased mortality in the matched patients.
Table 3 shows that the use of a RAwas a strong predictor
of decreased MAEs in diabetic patients (OR, 0.32; 95%
CI, 0.15-0.68; P ¼ .003), obese patients (OR, 0.15; 95%
CI, 0.06-0.39; P<.001), COPD patients (OR, 0.05; 95%
CI, 0.01-0.57; P ¼ .016), and those patients older than 60
years (OR, 0.40; 95% CI, 0.20-0.79; P ¼ .009). However,
Table 3 shows that use of a RA significantly improved
survival only in patients with COPD (HR, 0.49; 95% CI,
0.24-0.98; P ¼ .045) and with age older than 60 years
(HR, 0.71; 95% CI, 0.51-0.99; P ¼ .050). Overall survival
in these other subgroups of patients was not statistically
different between the RA and RITA patients.RITA 278 Reference
Adjusted for age, sex, previous myocardial infarction, femoral popliteal disease,
aorto-iliac disease, cerebrovascular disease, stroke, diabetes, COPD, creatinine level
>2.5 mg/dL, hemodialysis, and triple-vessel disease. EF, Ejection fraction;
HR, hazard ratio; OR, odds ratio; RA, radial artery; RITA, right internal thoracic
artery; COPD, chronic obstructive pulmonary disease; CI, confidence interval.
ALITA/SV Patient Outcomes
To address the possibility that surgeon or institutional
practice differences and not the choice of conduit caused
the different RA versus RITA outcomes, we first compared
our New York State Department of Health risk-adjusted
mortality rates for all isolated CABG over the 14-year
period of the study. There was no difference in mortality
rate (BIMC, 2.22%; SLR, 2.35%; P ¼ .562). Second, in
the concurrent group of matched SITA patients, the
Kaplan-Meier 1-, 5-, and 10-year survival rates were
95%, 83%, and 66%, respectively, for BIMC, and were
92%, 79%, and 66%, respectively, for SLR patients
(P ¼ .07, log-rank test), and MAE rates were similar
(RA, 21% vs RITA, 24%; P ¼ .22). In addition, Cox
regression modeling showed no difference in mortality
(HR, 1.00; 95% CI, 0.84-1.20; P ¼ .938), and logistic
regression showed no difference in the rate of MAEs
(OR, 0.76; 95% CI, 0.53-1.08; P ¼ .134). The SLR
4.6% stroke rate (compared with 1.2% at BIMC) wasTABLE 2. Independent predictors of mortality in 1056 matched RA
and RITA patients after CABG/LITA
HR 95% CI P value
Radial artery use 0.85 0.64-1.13 .277
Femoral PVD 2.31 1.57-3.42 <.0001
Age per year 1.06 1.04-1.08 <.0001
Diabetes 1.55 1.17-2.07 .003
Hypertension 1.63 1.17-2.27 .004
COPD 1.66 1.16-2.36 .005
Ejection fraction 0.99 0.98-1.00 .010
CHF 1.59 1.10-2.31 .015
CHF, Congestive heart failure; PVD, peripheral vascular disease; COPD, chronic
obstructive pulmonary disease; HR, hazard ratio; CI, confidence interval.
The Journal of Thoracic and Cathe only MAE that was significantly different (Sidak-
adjusted P ¼ .011); there were no differences in the
respiratory failure rate at BIMC (5.4%) versus SLR
(8.4%) (Sidak-adjusted P ¼ .555) and the sternal infection
rates (1.1% at BIMC vs 0.9% at SLR). These similar
overall outcomes in all CABG patients and in the
concurrent SITA patients suggest similar institutional
practices and further suggest that the differences in RA
versus RITA MAEs are the result of the choice of conduit
and not the institution.
Graft Patency
Of the total cohort of 2488 patients, 343 patients (13.8%)
had symptom-driven cardiac catheterization at our institu-
tions 0.1 to 15.5 years after CABG. The mean time to cathe-
terization was 5.2  3.7 years at BIMC and 5.0  3.9 years
at SLR. The total percentage of patients undergoing
catheterization at BIMC was 17.7% (236 of 1334 patients)
and at SLR was 9.3% (107 of 1154 patients).
Overall, a total of 1372 anastomoses in 236 RA and 107
RITA patients were evaluated. Overall patency for the RA
was 83.9% (276 of 329 anastomoses) and, for the RITA,
patency was 87.4% (160 of 183 anastomoses), which was
not statistically different (P ¼ .155). Overall (343 patients)
LITA patency was 92.7% in 396 anastomoses and SV
patency was 56.7% in 464 anastomoses. LITA
(P<.0001), RITA (P<.0001), and RA (P<.0001) patency
were each significantly better than SV patency.rdiovascular Surgery c Volume 147, Number 1 137
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in 5 patients) and Y grafts (36 anastomoses in 18 patients)
was 78% (36 of 46) versus a single RA to circumflex
aortocoronary graft patency of 84.8% (240 of 283)
(P ¼ .339). RITA sequential (132 distal anastomoses in
61 patients) and Y graft (12 distal anastomoses in 6 patients)
combined patency was 86.8% (125 of 144) versus 87.5%
(35 of 40) patency for single RITA grafts to the circumflex
coronary artery (P ¼ .908).
DISCUSSION
Our 18-year study of 528 matched pairs of CABG-LITA
patients comparing RA and RITA grafts to bypass the left
circumflex coronary artery is the largest reported series
attempting to better define the second best arterial graft.
We compared long-term survival in our 2 affiliated centers
each committed to arterial grafting, one using the RA and
the other using the free RITA. We found that long-term
survival was similar in CABG-LITA patients receiving
either the RA or free RITA to bypass the circumflex
coronary artery. Major adverse events were fewer with the
RA and use of the RA was protective from MAEs,
especially in diabetic, obese, COPD, and older patients. In
addition, COPD and older patients had better survival
with RA grafting. Midterm RA patency was similar to
RITA patency.
There are few previous studies comparing the RA versus
the RITA in patients undergoing CABG with the LITA. All
studies lacked long-term follow-up evaluation and all
included a high proportion in whom the second arterial graft
bypassed the right coronary artery. Most studies supported
the RA or found no survival differences. Caputo et al13
found similar survival at 18 months in 325 RA (62% to
the circumflex coronary artery) and 336 RITA (6% as
free grafts and 47% to the circumflex) unmatched patients.
They concluded that the use of the RA (preferentially used
in diabetic, older, and COPD patients) had a strong
protective effect against all causes of death. Hayward
et al14 reported similar 5-year survival and patency in a
prospective randomized controlled trial (RCT)—the Radial
Artery Patency and Clinical Outcomes trial—in patients
younger than 70 years, comparing the RA (198 patients)
with the free RITA (196 patients) to bypass the next best
coronary artery (which was the circumflex coronary artery
in 54% of the RA group and 61% in the RITA group).
They found significantly improved adjusted event-free
survival at 18 months with use of the RA. RA patency
was 94% and RITA patency was 87%. In the only other
RCT comparing RA with RITA grafting, Nasso et al15
found no difference in survival at 3 years between 202
RA (77% to the circumflex) and 198 free RITA (74% to
the circumflex) patients. Our overall findings are consistent
with these 3 smaller, midterm studies supporting use of the
RA versus the RITA (mostly as free grafts).138 The Journal of Thoracic and Cardiovascular SurgOne study supported the RITA and reported quite poor
outcomes using the RA. Ruttmann et al16 reported much
better event-free survival at 33 months in 277 RITA
(42% as free grafts) patients propensity matched to 277
RA patients. Patency of the RA (62%) was inferior to
ITA (90%) and even SV (79%) patency. The striking
finding of this study was the disproportionally high rate of
postoperative complications in the RA patients. The rates
of postoperative myocardial infarction (3.6%) and stroke
(3.6%) were each 9-fold higher in the RA patients than in
the RITA patients. The rates of reoperation for bleeding
(6.5%) and sternal dehiscence (3.6%) in RA patients
were also much higher than usually reported. They also
reported that 8 RA patients needed emergent redo CABG
for acutely failed RA grafts, an event we have not observed
in more than 1850 RA patients.17 These unusual findings
may reflect major differences in the harvesting, deploy-
ment, and surgical techniques of RA grafting. These
limitations clearly undermine the validity of the conclusion
by Ruttmann et al16 that the use of the RITA but not the
RA improves long-term survival after CABG. Thus, our
findings and a critical review of the available RA versus
RITA literature suggest a similar survival rate using
either the RA or RITA with a trend toward better
event-free survival using the RA.
We found a very strong protective effect of RA grafting
on MAEs. The lower rates of sternal wound infection and
respiratory failure in the RA patients suggest the cautious
use of bilateral internal thoracic artery (BITA) harvesting
in obese, diabetic, older, and COPD patients at risk for these
complications. Although there may be somewhat differing
protocols for ventilator management at our 2 institutions,
there is a general consensus to extubate patients as early
as possible and to re-intubate a patient when clearly indi-
cated. Although the differing rates of respiratory failure
may be related to institutional practices, we believe that
the likely factor causing the difference is the choice of
conduit in selected patients. In diabetic patients, we found
a highly significant protective effect of RA grafting on
MAEs (Table 3). Compared with SV grafting, Hoffman
et al20 have shown survival benefits and Singh et al21 have
shown patency benefits of RA grafting in diabetic patients.
In addition, Dorman et al22 and Puskas et al3 recently re-
ported a clear survival benefit of BITA grafting compared
with SITA grafting in diabetic patients without a statisti-
cally significant difference in sternal wound infections,
although Puskas et al3 reported an adjusted 85% increase
in sternal infections in the BITA group. Taggart et al23 found
a clear increase (1.9% vs 0.6%; RR, 3.24) in sternal wound
infections in the only RCT comparing BITA with SITA
grafting. The evidence thus strongly supports additional
arterial grafting in diabetic patients and, although not
universal, there appears to be a significantly increased risk
of sternal wound infections in diabetic patients receivingery c January 2014
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decision not to pay for a sternal wound infection, defined as
a ‘‘never event,’’ adds to the appropriate reluctance to use
BITA grafting in diabetic (as well as in obese and COPD)
patients. RA grafting is an excellent alternative to RITA
grafting in diabetic and other patients at high risk for
MAEs. Nonetheless, RITA grafting is still superior to SV
grafting in all patients and both RA and RITA grafting
have clearly documented long-term survival benefits
compared with SV grafting.
The RITA is believed to be the better conduit by many
surgeons based on anecdotal experience and a sense of
less predictable RA patency12 despite multiple studies
showing excellent (from 82% to 98%) 1- to 7-year RA
patency.17,24-28 The most frequently cited evidence for
poor RA patency is the study by Khot et al.29 They found
a 51% RA patency at 18 months in 310 of 27,211 patients
undergoing cardiac catheterization from 1996 to 2001.
However, 22% of these 310 patients had reoperative
CABG and only 63% received postoperative antispasm
medication. In addition, 25% of these patients had a
RITA graft, suggesting that the RA was used for third- or
fourth-order target vessels. This study had clear limitations
in comparing contemporary RA patency in primary CABG
procedures performed in patients with the RA used for
second-order target vessels. Thus, the majority of the
literature and our results support excellent midterm patency
of RA conduits.
We found equivalent 5-year RA and RITA patency as did
the Radial Artery Patency and Clinical Outcomes investiga-
tors.30 They subsequently reported a 90% RA patency and
an 83% RITA patency that was similar to our 83.9% RA
patency and 87.5% RITA patency. In addition, Tatoulis
et al28 found a RA patency of 89% at 4 years in their study
of 1108 RA angiograms. They also noted a 92.5% patency
in RA grafts in place more than 5 years, leading the
investigators to conclude that late patency of RA grafts is
similar to reported RITA patency. However, in a later report,
Tatoulis et al31 found 10- and 15-year RITA patency of 90%
and 79%, respectively, in their large study of 991 RITA
angiograms. They also found that 10-year RA patency
was now only 78%, leading the investigators to alter their
previous conclusion. They now suggest that RITA patency
probably is better than RA patency, although long-term
RA patency data were limited. The majority of the literature
thus suggests a RA midterm patency very similar to RITA
patency but, clearly, more long-term studies are needed to
better define the late patency of RA grafts.
Our study had several important limitations. It was a
retrospective study subject to patient selection bias. In
addition, different institutional arterial grafting preferences
and practices resulted in significant heterogeneity between
the RA and RITA patient groups. Propensity matching was
thorough and designed to minimize patient selection bias,The Journal of Thoracic and Cabut there remains a possibility of uncontrolled confounding
effects and that the difference in outcomes was the result of
the different institutions’ practice and not the choice of
conduit. We further addressed this bias by using the propen-
sity score in logistic and regressionmultivariable analyses in
all unmatched RA and RITA patients, which confirmed our
propensity-matched findings. In addition, we compared our
overall 14-year NewYork State risk-adjustedmortality rates
for our 2 institutions and performed a propensity analysis of
concurrent SITA patients and neither found any differences
in outcomes, suggesting similar institutional and surgeon
practices and systems of care. Available hospital data points
were limited to those reported to the New York State
database. All-cause mortality was used to determine
survival; the cause of death and other cardiac events were
not available. Cardiac catheterization data were limited to
only our institutions and the mechanism of graft failure
was not determined. Our RITA grafts were all free, pedicled
grafts, which possibly lack the potential long-term survival
benefits of in situ grafts (although Tatoulis et al31 showed
identical 10-year patency of free and in situ RITA grafts,
which strongly suggests equivalent free and in situ RITA
long-term survival), and the possible lower sternal infection
rates of skeletonized BITA grafts.32 Finally, therewere clear
differences in the practices of our 2 institutions that may
have contributed to the differences in short-term outcomes.
In particular, the greater commitment to more complete
arterial grafting using sequential grafting and the use of
the surgical microscope resulted in longer bypass times,
which may have contributed to the higher MAE rates in
the RITA patients. The findings of Fuqui et al33 and our
finding of equivalent patency in sequential and single free
RITA grafts strongly suggests that long-term survival is
not impacted negatively by using sequential grafts.
We conclude that either the RA or free RITAmay be used
to achieve the well-documented survival benefit of multiple
arterial grafting, but COPD or older patients probably
should have a RA graft. The second best arterial graft to
bypass the circumflex coronary artery during CABG with
LITA may be the RA given the high rates of diabetes,
obesity, and lung disease in the increasingly elderly patients
undergoing CABG. Finally, multiple arterial grafting is an
important strategy during CABG and the choice of the
second arterial conduit should be guided by patient profiles
and surgeon preferences.References
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Dr James Tatoulis (Parkville, Victoria, Australia). I have no
disclosures but I am an advocate for arterial grafts.
Dr Tranbaugh, congratulations on the delivery, content, and
clarity of your presentation. It is 40 years since Carpentier first
introduced the radial artery, 20 years since its resurrection by
Acar, and bilateral ITAs have been used for over 30 years, yet
fewer than 10% of coronary bypass operations worldwide have
2 or more arterial grafts. Dr Tranbaugh and his colleagues are
to be commended on an excellent further contribution to the
knowledge on arterial grafts.
Having previously shown superior long-term survival for LITA
plus radial artery over LITA plus saphenous vein graft, they have
now focused on the pragmatic question: which is the best second
arterial graft, the radial or the RITA? The radial is long, robust,
there are 2, it is easy and quick to harvest, and not burdened
by sternal and pulmonary problems. The RITA, however, is
biologically identical to the left ITA, universally acknowledged
to be the best graft.
Their excellent, large, propensity-matched patency and
outcome study spanning 18 years show similar excellent survival
at 10 years, 85% and 80%, and similar patency, 84% and 87%,
for the radial and RITA, respectively. However, there were more
major adverse events in the RITA group: stroke, sternal infection,
and respiratory failure. None significant individually but together
they were. Hence, the clinical results favored the radial over the
RITA, especially in obese patients and those with diabetes and
chronic obstructive pulmonary disease.
I have a few questions. There were no contraindications to
using the RITA, and in this group, a side-biting clamp was
used, but not in the radial group. Can you please comment on
the possible contribution of side-biting clamps to the higher
stroke rate and whether the surgical strategy and techniqueery c January 2014
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graft?
Dr Tranbaugh. Thank you very much, Dr Tatoulis, for your
kind comments and your excellent point. The difference in stroke
rates between the radial artery and RITA patients was likely due to
using the single-clamp technique versus the side-biting clamp for
the proximal anastomoses. Our practice is to use the single-clamp
technique, which likely decreases the risk of stroke. We did not
specifically look at that in this study, but that certainly was one
of the suggestions of our study.
Dr Tatoulis. Thank you. Obesity, diabetes, and chronic obstruc-
tive airway disease are known risk factors for sternal infection and
pulmonary problems in bilateral ITAs, and these could be possibly
ameliorated by a skeletonized harvest. Will these findings
encourage your group to avoid BITA in such patients or use
skeletonized rather than pedicled ITAs?
Dr Tranbaugh. We do not have experience with skeletonized
ITAs and we have used the pedicled approach. I certainly think
that the enthusiasm for bilateral ITAs in obese diabetics with
this data has changed the outlook at St. Luke’s, and I think
appropriately so.
Dr Tatoulis. Finally, spasm and competitive flow are significant
problems for arterial grafts, and the radial is especially vulnerable.
Can you briefly describe your strategy to overcome these issues
both in the study and in your group’s daily practice?
And, as an addendum, can I possibly entice you to be a bit more
definitive in your conclusion? Do you think there is no difference
between those 2 grafts at 10 years or do you favor the radial?
Thank you for your excellent contribution.
Dr Tranbaugh. Thanks very much. Radial artery spasm is
real, as you well know, and I think it is very important to use a
no-touch technique. We harvest the radial using an endoscopic
technique, which we feel is a bit safer; for the last 13 years it
has been our preferred technique. We are very cautious in the
operating room, using heparinized blood with diltiazem and
papaverine to gently irrigate the radial. We keep patients on
intraoperative diltiazem and then postoperatively switch to
intravenous nitroglycerin and maintain the patients for 6 months
on long-term oral nitrates.
We have, fortunately, seen very little acute spasm of the radial
artery. We have only had one intraoperative case where we had
to go back and put a vein graft on the circumflex. So I think these
techniques work very, very well.
Long term, one of the questions with spasm is bypassing the
correct vessel with the correct amount of proximal disease. Early
on we were not so focused on that, and I think that probably
explains some of our graft failures. More recently, we have really
restricted the use of the radial artery to patients with proximal
stenoses of greater than 80%.
And your last question about what graft dowe really prefer, a lot
depends on the comfort level of the surgeon and the patient profile.
We have become extremely comfortable with the radial artery and
think it is a great conduit as an alternative to the RITA. With so
many of our patients being obese and diabetic, we believe these
patients benefit by avoiding bilateral ITA grafts. It really depends
on the right operation for the right patients with the surgeon being
most comfortable.
Dr Tatoulis. Thank you.The Journal of Thoracic and CaDr Antonio Laudito (Duluth, Minn). I want to thank you for
your effort, but I am very concerned because your study started
with the acceptance of 5% utilization of bilateral mammary use
in CABG, because if we take this approach, we have also only
35% performance of mitral valve repair. That does not mean that
we give up the mitral valve. The ability to appreciate the BITA
value is due to skeletonization and use in situ. If you use the
RITA as a free graft, you lose the benefit. Of course, with the radial
where you are a master, from your experience, you are achieving
the same results. But the BITA patient in situ use and skeletonized,
as you can see from the series from Tohru Asai from Japan
(the Japanese are examples in the world) and from our own series
in the United States with Dr Puskas, even in diabetics, even in fat
people, in proper hands achieve the best result in arterial revascu-
larization. We need to open our eyes and accept that it requires
time, it is not the usual quick CABG, and is a different quality
of revascularization. But this will cancel redo coronary surgery.
I think, following the spirit of this organization and what our
president said yesterday, we should push and support, despite the
difficulties, what is the best for our patients.
Dr Tranbaugh. There is no doubt we need to do more arterial
grafting. We do not have any experience with skeletonization. We
are well aware of the data and publications, and it certainly may be
of significant benefit to patients.
Dr John Puskas (Atlanta, Ga). Dr Tranbaugh, I congratulate
you on a well and vigorously conducted trial and study. I have
real concern, though, about the end points of stroke and sternal
wound infection because I think it makes a great deal of difference
how we do this operation, whether it be a BITA or whether it be a
radial artery. I would echo concern of using the RITA as a free
graft. It is a far more effective conduit as an in situ conduit. I think
the clamp on the aorta is a likely explanation for that higher stroke
rate in the BITA patient population. Sternal wound infection is
indeed a more frequent complication with BITA harvest than
with SITA harvest, but, again, it matters how you do it.
I think it matters what the patient’s hemoglobin A1c is pre-
operatively, and I think it matters a great deal how we open the
chest, how we harvest that ITA as a skeletonized conduit, and
how we close the chest. Those things have a very major impact
on morbidity. But we do know that BITA grafting has a very
significant impact on long-term survival in comparison with
SITA grafting.
The histology of the radial artery is strikingly different from the
histology and physiology of the IMA. How do you explain
physiologically the conclusion you have reached from this clinical
observation study?
Thank you for your analysis.
Dr Tranbaugh. Let me just go back for 1 second. The issue of
the free graft versus the in situ graft was not addressed, but
certainly Dr Tatoulis has shown that the patencies are identical
for those 2 strategies.
The stroke rate was unrelated to the conduit that we chose, and I
just wanted to re-emphasize that. And as far as the histology and
the biochemical aspects and the physiology of the different grafts,
it is hard to speculate as to exactly how that translates into
patencies.
I think the take-home message is that we are not doing enough
arterial grafting. In the United States it has really been stuck at 5%,rdiovascular Surgery c Volume 147, Number 1 141
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use. We have increased our radial use in the past several years to
70% to 80%, and year to date this year we have done 90% of
patients with the radial artery. So I think there is an opportunity
to do more arterial grafting, and, when properly harvested and
deployed, the radial artery works extremely well, has excellent
patency, is equivalent to the RITA, and is a whole lot better than
vein grafts.
Dr Xin Chen (Nanjing, China). In China, our studies show in
diabetic patients the radial artery has more chance to get
atherosclerotic lesions. Have you noticed that in the US patients?
The second question is, I noticed from your slides there is a big
difference between the pump time of the RITA and radial.
What is the main reason for that? Is there any technical issue or
something else?
Thank you.142 The Journal of Thoracic and Cardiovascular SurgDr Tranbaugh. I will answer your last question first. The pump
time differences were primarily because Beth Israel surgeons did
both proximals and distals using a single cross-clamp, the St.
Luke’s surgeons used a partial occluding clamp for the proximals.
They also used a lot of sequential grafting, that just took extra
time. So the perfusion differences were really related to the
technique.
Radial arteries in diabetics can be calcified, and it is usually
a diffuse calcification. We have occasionally used those grafts
just because there have not been any other grafts available,
and they function well. They are sometimes a little difficult
to deal with and drive the needle through the areas of calci-
fication, but it seems those grafts actually function well. They
are not prone to spasm, they are so rigid that they cannot go
into spasm. So, occasionally, we have used those grafts in
diabetics.ery c January 2014
